Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Auteurs

P. Cottu, V. D'Hondt, S. Dureau, F. Lerebours, I. Desmoulins, P.-E. Heudel, F.P. Duhoux, C. Levy, M.-A. Mouret-Reynier, F. Dalenc, J.-S. Frenel, C. Jouannaud, L. Venat-Bouvet, S. Nguyen, J.-M. Ferrero, J.-L. Canon, J. Grenier, C. Callens, D. Gentien, J. Lemonnier, A. Vincent-Salomon, S. Delaloge